Tanta University: Inflammatory Bowel Diseases trials
The registry lists 11 Inflammatory Bowel Diseases studies with Tanta University as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 2 8Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Impact of Hepatitis B Virus on Inflammatory Bowel DiseaseRecruitingNCT06881238
- Metformin as Added on Therapy in Patients With Ulcerative ColitisRecruitingNCT05574387Phase 2
- Optical Coherence Tomography Angiography Assessment of Retinal Lesions in Inflammatory Bowel DiseasesRecruitingNCT04601805
- Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative ColitisCompletedNCT05781698Phase 2
- Fenofibrate in Ulcerative ColitisCompletedNCT05753267Phase 2/3
- Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.CompletedNCT05575505Phase 2
- Atorvastatin Efficacy and Safety in Patients With Ulcerative ColitisCompletedNCT05567068Phase 2
- Atorvastatin in Patients With Ulcerative ColitisCompletedNCT05561062Phase 2
- Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative ColitisCompletedNCT05558761Phase 2
- Metformin in Patients With Ulcerative Colitis Treated With MesalamineCompletedNCT05553704Phase 2
- Detection of Helicobacter Pylori in Ulcerative Colitis PatientsStatus unknownNCT03172000Not applicable